Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Amy R. MacKenzie"'
Autor:
Amy R. MacKenzie, Enrique Soto-Perez-de-Celis, Ronald J. Maggiore, Janette K. Merrill, Grant R. Williams, Kimberly T Smith, William Dale, Heidi D. Klepin, Sweatha Katta
Publikováno v:
JCO Oncol Pract
PURPOSE: For patients with cancer who are older than 65 years, the 2018 ASCO Guideline recommends geriatric assessment (GA) be performed. However, there are limited data on providers’ practices using GA. Therefore, ASCO’s Geriatric Oncology Task
Autor:
Janell L. Pisegna, Karlynn BrintzenhofeSzoc, Armin Shahrokni, Beverly Canin, Elana Plotkin, Leigh M. Boehmer, Leana Chien, Mariuxi Viteri Malone, Amy R. MacKenzie, Jessica L. Krok-Schoen
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 31(1)
Care for older adults with cancer became more challenging during the COVID-19 pandemic, particularly in urban hotspots. This study examined the potential differences in healthcare providers' provision of as well as barriers to cancer care for older a
Autor:
Amy R. MacKenzie, Janell Pisegna, Beverly Canin, Jessica I. Krok-Schoen, Leigh Boehmer, Armin Shahrokni, Elana Plotkin, Karlynn BrintzenhofeSzoc
Publikováno v:
Journal of Geriatric Oncology
Objectives: Care for older adults with cancer became more challenging during the COVID-19 pandemic. We sought to examine cancer care providers' attitudes toward the barriers and facilitators related to the care for these patients during the pandemic.
Autor:
Amy R. MacKenzie, Michelle Lasota
Publikováno v:
American Society of Clinical Oncology Educational Book. :476-484
Conversations about death and dying are a crucial part of all medical care and are particularly relevant in the field of oncology. Patients express a desire to have discussions about goals of care, and many patients have thought about their end-of-li
Autor:
Leigh Boehmer, Amy R. MacKenzie, Janell Pisegna, Elana Plotkin, Karlynn BrintzenhofeSzoc, Jessica L. Krok-Schoen, Beverly Canin, Armin Shahrokni
Publikováno v:
Journal of Geriatric Oncology
Objectives Care for older adults with cancer became more challenging during the COVID-19 pandemic. We sought to examine healthcare providers' clinical barriers, patient questions, and overall experiences related to care delivery for these patients du
Autor:
John L. Wagner, Lindsay Wilde, Neil Palmisiano, Ubaldo E. Martinez-Outschoorn, Pierluigi Porcu, Gina Keiffer, Joanne Filicko-O'Hara, Dolores Grosso, Allison Zibelli, Matthew Carabasi, Neal Flomenberg, Michael Millenson, Onder Alpdogan, Thomas R. Klumpp, Usama Gergis, Amy R. MacKenzie, Adam Binder, Margaret Kasner
Publikováno v:
Blood
Introduction :The emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and subsequent coronavirus-19 (COVID-19) pandemic has impacted hematologic malignancies (HM) care worldwide. Reported risk factors for severe COVID-19 pre
Autor:
Andrea M. Barsevick, Scott W. Keith, Ronald E. Myers, Evan Lapinsky, Amy R. MacKenzie, Sarah E. Hegarty, Sheel Patel, Andrew E. Chapman, Joshua Schoppe, Ulysses Williams Iii
Publikováno v:
J Geriatr Oncol
Publikováno v:
Current oncology reports. 21(9)
Health-related quality of life (HRQoL) is a topic of great importance among older patients with cancer. Here we review the literature on HRQoL in older patients with colon and rectal cancer. HRQoL in older cancer patients with colon and rectal cancer
Autor:
Enrique Soto-Perez-de-Celis, Mina S. Sedrak, Tina Hsu, Kah Poh Loh, Jessica L. Krok-Schoen, Melisa L. Wong, Amy R. MacKenzie, Ishwaria Mohan Subbiah, Allison Magnuson, Carolyn J Presley, Junior Cancer, Grant R. Williams, Daneng Li
Publikováno v:
Journal of geriatric oncology. 11(2)
Autor:
Lincoln Pasquina, Abba Elizabeth Theogaraj, Johannes Noe, Magalie Hilton, Adham Adel Jurdi, Amy R. MacKenzie, Basem Goueli, Razelle Kurzrock, Walter Bordogna, Erika Ferreira, Bettyna Brivet-Jones, V. Archer, Christine M. Lovly
Publikováno v:
Journal of Clinical Oncology. 39:TPS3155-TPS3155
TPS3155 Background: Anaplastic lymphoma kinase ( ALK) fusions are found in 3–8% of non-small cell lung cancers (NSCLC) and ̃0.2% of other tumor types. Alectinib is a selective, CNS-active ALK tyrosine kinase inhibitor approved as first-line treatm